Background: We present a case series of upper extremity fibromuscular dysplasia (UE FMD) consisting of 22 patients from two tertiary referral centers focusing on clinical presentation, diagnostic findings, and interventional outcomes. FMD is a noninflammatory, nonatherosclerotic arteriopathy that has a predisposition for middle-aged women. Involvement of the UE is thought to be rare. Patients with UE FMD can present with claudication or ischemia, or they can be incidentally diagnosed. The treatment approach is dictated by clinical presentation.
Fibromuscular dysplasia (FMD) is a noninflammatory, nonatherosclerotic arteriopathy that most commonly presents in middle-aged women. 1 Multifocal FMD is manifested as alternating areas of arterial stenosis and dilation and is classically described as a "string of beads" on angiography. 2 FMD may cause beading or stenosis, dissection, and aneurysm. The most common areas of involvement are the carotid and renal arteries, and although any medium-sized arterial bed may be affected, upper extremity (UE) FMD is considered rare. 1 The clinical presentation of UE FMD varies significantly. Patients have been reported to present with cyanosis, paresthesia, weakness from vascular insufficiency, gangrenous digits from microembolism with distal ischemia, pulsating mass in the UE, and incidental diagnoses in those without symptoms. 3, 4 Interestingly, of the UE FMD cases in the literature, there has been one case reported in a man and one case with familial involvement in a patient and her mother, who were both diagnosed with bilateral brachial FMD. 5, 6 Multiple interventions have been reported with varying degrees of success, including medical therapies with antiplatelet agents, anticoagulation, and calcium channel blockers. The use of percutaneous transluminal balloon angioplasty, catheter-directed thrombolysis, stellate ganglion block, and surgical interventions including endarterectomy and resection of the affected artery and surgical bypass have also been reported. [7] [8] [9] [10] Outcome data are scant in the literature and limited to two case studies of patients who underwent surgical intervention and one case study of a patient who underwent angioplasty of symptomatic lesions. The longest follow-up available is in a patient who presented with arm claudication and clubbing and underwent resection of the involved brachial artery with venous interposition graft that was reported to be patent at 6 years of follow-up. 6 From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland a ;
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Copyright Rice and Armstrong described a patient with right brachial artery FMD who presented with painful cyanotic digits that worsened with cold temperatures consistent with Raynaud phenomenon. 11 That patient underwent right brachial artery resection and grafting with reverse saphenous vein without recurrence of symptoms or stenosis of her graft after 3 years of follow-up. Yoshida et al described a patient with brachial FMD and painful cyanotic fingers who underwent angioplasty without recurrence of symptoms at 3.5 years of follow-up. 9 There is no consensus in regard to the invasive treatment of severe symptomatic UE FMD, but surgical intervention tends to be the mainstay of treatment for longer stenotic segments, whereas less invasive catheter-based interventions tend to be preferred in symptomatic short lesions. [11] [12] [13] [14] To date, a composite of 21 cases of UE FMD reported in the medical literature form the current knowledge base for the presentation, management, and prognosis of patients with UE FMD. 15, 16 We present a case series of an additional 22 patients with 29 limbs affected by UE FMD seen at two tertiary referral centers during 8 years from December 2009 to May 2016.
METHODS
Cases were identified from the patients seen at the Cleveland Clinic and the University of Virginia FMD specialty clinics. The study population was composed of patients whose UE FMD was diagnosed and managed at our institutions or who presented for a second opinion for the management of FMD after diagnosis and treatment at other facilities, at times several years after their diagnosis. The data were abstracted from available medical records, reports of imaging, and radiographic images that were reviewed personally by the evaluating vascular medicine attending physician to confirm UE involvement, lesion length, and location. This study was approved by the Institutional Review Boards of both institutions. Consent of the patient was not required for this retrospective chart review. The medical records of all patients included in each respective center's FMD clinical registry were queried for UE involvement. Study data were collected and managed using REDCap electronic data capture tools hosted at the Cleveland Clinic and the University of Virginia. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing an intuitive interface for validated data entry, audit trails for tracking data manipulation and export procedures, automated export procedures for seamless data downloads to common statistical packages, and procedures for importing data from external sources. 17 Demographic data, presenting UE symptoms, UE artery involved with FMD, involvement of FMD in other vascular beds, type of FMD, method of diagnosis and respective findings, and significant physical examination findings were included if documented in clinic notes. Completeness of physical examination data varied for two reasons: (1) patients who were initially evaluated at outside institutions at the initial diagnosis of UE FMD may not have had complete documentation of their UE physical examination; and (2) among providers in the FMD clinics, practice patterns evolved during 8 years to include bilateral auscultation of UEs as UE FMD became more recognized. Using modern nomenclature, the type of FMD was coded as multifocal if the typical beaded appearance was present. 2 Claudication was defined as intermittent UE pain associated with activity; ischemia was defined as rest pain or skin changes including cyanosis, nonhealing ulcers, and gangrene. If a patient had more than one presenting symptom, all symptoms were noted. Data on medical and invasive procedures, including endovascular and open surgical interventions, were also captured. Details of angiography, including lesion length and degree of stenosis, were also included if available for review. Procedural outcomes and degree of relief of symptoms during and after the index hospitalization were also recorded. Limbs with more than one procedure also had subsequent interventions and outcomes recorded. Time from most recent invasive procedure (if more than one invasive procedure was performed) to most recent imaging was calculated to provide overall patency data. Descriptive statistics were used to describe the population of patients and outcomes.
RESULTS
Of 658 FMD patients seen at the two sites, 22 patients and 29 limbs were diagnosed with UE FMD involvement. Not all patients had screening of all arterial beds, and thus the true prevalence of UE FMD is not able to be reported. This report includes only those patients for whom UE FMD was specifically investigated. Recommendation: This study suggests that for symptomatic patients with upper extremity fibromuscular dysplasia, medical therapy is frequently not sufficient. More than one procedure may be necessary for symptom relief, and endovascular treatment seems to have a higher failure rate.
ARTICLE HIGHLIGHTS
Of the patients with UE FMD, 91% (n ¼ 20) were female, and the mean age at presentation was 52.8 years (Table I) . Similar to published data from the U.S. Registry for FMD, the most commonly involved vascular beds were the carotid (n ¼ 17 patients [77.3%]) and renal (n ¼ 15 patients [68.2%]) arteries. 1 Only one patient of the 22 (4.5%) had brachial FMD without FMD involvement in any other vascular bed. Four patients (18.2%) experienced dissections in other vascular territories (Table II) . The brachial artery was the most common UE artery involved (n ¼ 26 limbs [89.7%]), followed by the subclavian (n ¼ 2 limbs) and axillary (n ¼ 2 limbs) arteries (both 6.9%) (all other "n" notations throughout the article refer to limbs unless specifically noted). Symptoms from FMD involvement in other vascular beds were not captured. All limbs with UE FMD had the characteristic beaded appearance of multifocal FMD (100%), and of the 17 patients who had bilateral UEs evaluated, 14 patients (82.4%) had bilateral involvement and 3 patients (17.6%) had unilateral involvement. Half of limbs (n ¼ 15 [51.7%]) with UE FMD were asymptomatic, and FMD was diagnosed from testing performed for a bruit (Fig 1) , from blood pressure discrepancy in the arms, or as an incidental finding on an imaging study. Among those with symptoms, the most common symptom leading to diagnosis was ischemic finger or hand (n ¼ 9 [31%]), followed by hand or arm claudication (n ¼ 8 [27.6%]). UE auscultation was not documented in the majority of limbs, but when auscultation was performed (n ¼ 14 limbs), brachial bruits were heard in 28.6% (n ¼ 4 limbs). When the Allen test was performed (n ¼ 17 patients), approximately 47% of patients (n ¼ 8) had an abnormal All asymptomatic limbs were treated with antiplatelet agents for thromboembolic prophylaxis, which likely served for treatment of all other vascular beds involved with FMD in these patients. Of the 14 symptomatic limbs, treatment was deferred for the limb of 1 patient, 5 limbs underwent invasive therapy, and 8 limbs (57.1%) were solely medically managed as the first intervention. The presenting symptoms, available lesion descriptions, primary and subsequent interventions, and available follow-up data are summarized in Table III . In those limbs that were medically managed, aspirin (n ¼ 4 [50%]) and heparin or low-molecular-weight heparin products (n ¼3 [37.5%]) were most commonly used (Fig 2) . Only two of the eight limbs (25%) that were medically managed experienced complete symptom relief; one limb was treated with heparin bridging to warfarin and the other with a combination of heparin bridging to warfarin, aspirin, and amlodipine. One limb presented as UE claudication and was found to have left ulnar artery occlusion and FMD involvement of the left axillary and brachial arteries and right axillary artery. Although antiplatelet therapy was recommended for this patient, she did not start therapy until she received a second opinion several months later after her symptoms had resolved (Fig 3) .
Of the five limbs that underwent invasive therapies as the first intervention, four limbs underwent angioplasty (80%) and one limb underwent thrombolysis (Fig 4) . The limb that underwent thrombolysis as the first intervention presented with sudden onset of a mottled and cool left hand consistent with acute limb ischemia. Left ulnar artery occlusion was diagnosed and believed to be secondary to brachial FMD. Lysis resulted in a patent left ulnar artery; however, thrombosis recurred, and she was readmitted and subsequently treated with heparin bridge to warfarin, aspirin, clopidogrel, and cilostazol with partial relief of symptoms. Of the 14 symptomatic limbs, only 28.6% (n ¼ 4) had complete symptomatic relief after the first intervention, medical or invasive (Fig 2) .
Of the 10 limbs with residual symptoms after the first intervention, invasive intervention was offered but deferred for 2 limbs (Fig 2) ; these 2 limbs had been treated with aspirin as the primary treatment for claudication symptoms. For those with residual symptoms after primary medical or invasive treatment, 6 of 10 limbs (60.0%) required an invasive procedure as the secondary intervention, but only 8 of 14 limbs (57.1%) required any invasive intervention, whether primary or subsequent. In summary, only 3 of 14 limbs required more than one invasive intervention, 2 after primary angioplasty and 1 after medical therapy.
Patients who presented with milder symptoms, such as claudication and Raynaud phenomenon, were more likely to receive medical therapy as the primary intervention (six of eight limbs). Those with more severe symptoms, such as digital ischemia or major artery occlusion (subclavian), were more likely to be treated with invasive therapies (angioplasty and thrombolysis) as the first intervention. The patients with the most severe symptoms (rest pain and digital ulcerations) or occlusion of a proximal UE artery (subclavian) underwent bypass surgery as the subsequent intervention. All limbs with arterial occlusion in this series (n ¼ 6) eventually required an invasive procedure for symptom relief (Table III) .
Bypass surgery was performed as a second intervention for three limbs with residual symptoms, one after medical therapy and two after angioplasty. In the first case, a 43-year-old woman who presented with left hand numbness, tingling, and cold sensation was diagnosed with left subclavian artery occlusion. Angioplasty resulted in recanalization of the subclavian artery and partial resolution of symptoms, but she had persistent left hand claudication and subsequently underwent left subclavian artery to common carotid artery transposition. Surgical pathology findings of the subclavian artery were consistent with FMD, and she reported complete resolution of her symptoms. Follow-up duplex ultrasound 6.4 years later revealed the graft to be patent. The second case was a 63-year-old woman who had color changes in her fingers for 2 years that progressed to left arm weakness and cyanotic color changes. UE pulse volume recordings were abnormal on the left. She was treated with intravenous heparin and was discharged on lowmolecular-weight heparin; however, symptoms progressed to rest pain and finger ulcerations. Angiography revealed bilateral brachial FMD and left brachial artery occlusion with distal reconstitution through collaterals. Angiography was not available for primary review at the time of data abstraction. Left brachial artery to radial bypass with reverse saphenous vein graft was performed, and she was discharged on anticoagulation for 1 year with complete resolution of her symptoms despite follow-up UE duplex ultrasound 244 days after bypass surgery demonstrating an occluded graft. The third surgical case was a 63-year-old woman with nonhealing ulcers on her right index and middle fingers and intractable hand pain. Angiography showed a 12-cm length of irregularity consistent with FMD in the brachial artery and occlusion of distal ulnar and radial arteries with multiple segmental occlusions of the branches of the common digital and proper digital branches in the first to fourth digits. Angioplasty of the right brachial artery was complicated by a dissection with no improvement in her symptoms. Ulnar artery reconstruction with reverse vein graft was performed with complete resolution of her symptoms.
For the two limbs that underwent angioplasty as the second intervention, both had complete resolution of symptoms (Fig 5) . Both of these angioplasties were performed in limbs that were treated with medication as the primary therapy. The limbs that were treated medically for persistent symptoms (one with medical therapy as the primary intervention and the other after thrombolysis) and the one that underwent sympathectomy as the second intervention had partial improvement of symptoms (Fig 4) . The patient who underwent sympathectomy had presented with left digital ischemia with discoloration of the first, second, and third digits and rest pain. Angiography revealed occlusion of the medial and lateral proper digital arteries of the second digit and princeps pollicis artery of the first digit. Angioplasty of the brachial artery was performed; however, the patient continued to have persistent rest pain and subsequently underwent left index and middle finger digital artery sympathectomy 1 month after angioplasty. After the sympathectomy, the patient had improvement of symptoms in the first and third digits but still with persistent pain and discoloration of the second digit, so she underwent left finger amputation at the level of the proximal interphalangeal joint with subsequent resolution of symptoms.
Follow-up imaging was available for 7 of 14 limbs and is described in Table III . Of those arteries of limbs that had undergone angioplasty as the final invasive procedure and had available imaging (n ¼ 2), all were patent at follow-up during a mean of 3.2 years. Two of three (66.7%) surgical grafts remained patent during a mean of 3.2 years (Table III) . The limb treated with thrombolysis demonstrated patency of the affected brachial artery at 1.3 years. One interesting case included a patient who had new symptoms approximately 11 years after she was treated medically. This patient had initially presented with left middle finger discoloration and underwent angioplasty that revealed a nonoccluded brachial artery affected by FMD; she was treated with Patient coded as complete relief; however, this is a special case in which she presented again 11 years later with ischemic digit color changes and rest pain and underwent anticoagulation with low-molecular-weight heparin and warfarin for 3 months and angioplasty with subsequent complete relief of symptoms. c Patient had a third intervention 8 months after sympathectomy in which she underwent digital amputation at the level of the proximal interphalangeal joint because of rest pain.
anticoagulation using low-molecular-weight heparin as a bridge to warfarin with complete symptom relief. She then followed up locally at her own institution for approximately 11 years and presented again with discoloration and rest pain of multiple digits. Angiography revealed FMD of the left brachial artery involving 13.9 cm without occlusion; she was restarted on anticoagulation with low-molecular-weight heparin and warfarin for 3 months and then underwent angioplasty with subsequent complete symptom relief.
DISCUSSION
Current knowledge about the diagnosis and management of UE FMD is limited to single case studies and small case series. This study demonstrates that UE FMD tends to involve the brachial arteries bilaterally and to be the multifocal type. In the majority of cases (95.5%), patients with UE FMD tend to have FMD involvement in other vascular territories. Brachial bruits were heard in 28.6% of limbs (when auscultation was performed), and the Allen test result was abnormal in 47% of patients (when this maneuver was performed). Coupled with the finding that half the limbs in our series were asymptomatic, these results support the importance of the UE physical examination in patients with known FMD elsewhere, the importance of imaging in patients with abnormal UE physical examination findings, and the importance of contralateral imaging in those with known UE FMD. When symptoms of UE FMD are present, they are suggestive of vascular insufficiency, including claudication and ischemic symptoms such as cyanosis, digital ulceration, paresthesia, and rest pain.
Given the retrospective nature of this study, conclusions about the optimal treatment modalities for UE FMD must be tempered by the knowledge of the potential inherent bias of physicians to treat more severe symptoms and signs with more invasive therapies. In addition, missing data of lesion characteristics because of the inability to perform primary review of imaging in some patients also prevents the generation of comprehensive management recommendations based on patient and anatomic factors. Being cognizant of these limitations, we report that medical therapy as the primary treatment modality provided complete relief in only one-quarter of patients presenting with symptomatic UE FMD, although two patients in this group were lost to follow-up. Primary angioplasty also provided complete relief of symptoms in only one of four limbs, although this finding is likely to be reflective more of the increased severity of presenting symptoms in the patients referred for angioplasty (rest pain and digital ulcerations) than of the inferiority of the procedure itself. More than half of symptomatic limbs require an invasive intervention, but in this series, only 3 of 14 limbs needed more than one procedure (angioplasty followed by bypass surgery or sympathectomy) for severe symptoms. Despite the need to trial additional medications or to proceed with an invasive procedure, 9 of 12 limbs (2 limbs lost to follow-up) achieved complete symptom relief. Follow-up imaging was available for 7 of 14 patients. Variability in the completeness of records for procedures performed at outside institutions before evaluation at our two centers and the lack of consensus on intervals of surveillance testing after intervention for UE FMD limit the ability to provide complete patency data. We did find, however, that angioplasty procedures are durable, with arterial patency demonstrated out to a mean of 3.3 years. Two of three limbs requiring bypass surgery were patent out to 3.2 years; however, the patient for whom the brachial-radial artery bypass graft was noted to be occluded on follow-up imaging stated complete symptom relief. Overall, these numbers are small, and our ability to assess long-term patency after invasive treatment of UE FMD is limited. Fig 5. A 63-year-old patient presented with left dusky hand after failed medical treatment and subsequently underwent successful angioplasty of the brachial artey with complete symptom relief. There is beading associated with multifocal fibromuscular dysplasia (FMD) of the left brachial artery (A), which becomes less obvious after angioplasty (B). She also had FMD involvement of her right renal artery, bilateral external iliac arteries, and right brachial artery. FMD is considered a rare disease, and UE FMD, although uncommon, is likely to be underdiagnosed as half of the patients in our study were asymptomatic. There is currently no consensus for screening for UE involvement in those with FMD in other vascular territories. It is unknown which factors predispose an affected artery to cause symptoms, and in the short duration of follow-up of this study, no limbs that were asymptomatic became symptomatic.
There are inherent limitations in a retrospective case series, including lack of a surveillance imaging protocol in those with symptomatic disease after intervention or even a surveillance imaging protocol in those with asymptomatic disease. Incomplete records regarding physical examination, lack of imaging available for review for patients who had intervention at an outside institution, and variable follow-up imaging and clinical data also present difficulties for making firm recommendations for treatment; however, all limbs with clinical follow-up had achieved complete (n ¼ 9 of 12) or partial (n ¼ 3 of 12) relief of symptoms. Based on the outcomes described in this study, an algorithm for the management of patients with symptomatic UE FMD is provided in Fig 6. Angioplasty and surgical bypass procedures often do not occur in isolation but in conjunction with medical therapy. Anticoagulants and antiplatelet therapies were the most commonly used medications in this series, whether as primary therapy or adjunctive to invasive intervention. Their use depends on the angiographic appearance of affected arteries (beading vs thrombosis vs dissection vs occlusion) and the presence of distal embolization. Comments regarding the comparative efficacy of these medical therapies for the treatment of UE FMD are limited by a lack of comparative outcomes data and are beyond the scope of this case series. algorithm. Asymptomatic patients or patients presenting with mild symptoms of arm claudication that are nonlimiting can be treated with medical therapy alone. However, patients presenting with limiting symptoms or signs of severe limb ischemia, such as digital ulcers or skin discoloration related to distal embolization, should be considered for an initial approach of endovascular therapy. Patients with severe arm claudication that is lifestyle limiting can also be considered for endovascular therapy. Balloon angioplasty alone would be considered an initial choice especially in the absence of long-segment occlusions or distal vessel occlusions. Patients with distal embolization causing occlusions of the wrist or distal arteries may require additional therapies, such as lytic therapy or surgical reconstruction to restore flow or even sympathectomy for pain relief. In situations in which there is long-segment occlusion of the site where FMD is present that is not amenable to an endovascular approach, an initial surgical approach can be considered.
